CDH11 is increased in invasive breast cancers (Figure 1A-C, Supplementary Fig. S1B-E) [11-16] and in DCIS when compared to normal tissue (Figure 1C, Supplementary Fig. S1E)[12;16]. Here, CDH11 is linked to ductal breast carcinoma in situ.